{
    "Trade/Device Name(s)": [
        "OneTouch Verio Flex Blood Glucose Monitoring System",
        "OneTouch Verio Flex\u2122 Blood Glucose Monitoring System"
    ],
    "Submitter Information": "LifeScan Europe, a Division of Cilag GmbH International",
    "510(k) Number": "K150214",
    "Predicate Device Reference 510(k) Number(s)": [
        "K131363"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "June 25, 2015",
    "Summary Letter Received Date": "July 02, 2015",
    "Submission Date": "May 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "OneTouch Verio Flex Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric detection",
        "Electrochemical reaction"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancing Device",
        "Sterile Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for OneTouch Verio Flex Blood Glucose Monitoring System for self-testing of blood glucose in diabetic patients using fresh capillary whole blood.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood drawn from the fingertip for self-testing by individuals with diabetes at home as an aid to monitor diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}